Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Mateos

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|January 20, 2004
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trialM Gómez-Núñez, R Martino, M D Caballero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP Moreau, J San Miguel, P Sonneveld, et al.
Bone Marrow Transplantation|September 26, 2019
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantationT Caballero-Velázquez, C Calderón-Cabrera, L López-Corral, et al.
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
Leukemia|January 9, 2015
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolutionN Puig, I Conde, C Jiménez, et al.
Leukemia|May 3, 2016
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myelomaV González-Calle, J Dávila, F Escalante, et al.
Leukemia|May 9, 2012
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma statusL López-Corral, M E Sarasquete, S Beà, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|January 20, 2004
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trialM Gómez-Núñez, R Martino, M D Caballero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP Moreau, J San Miguel, P Sonneveld, et al.
Bone Marrow Transplantation|September 26, 2019
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantationT Caballero-Velázquez, C Calderón-Cabrera, L López-Corral, et al.
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
Leukemia|January 9, 2015
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolutionN Puig, I Conde, C Jiménez, et al.
Leukemia|May 3, 2016
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myelomaV González-Calle, J Dávila, F Escalante, et al.
Leukemia|May 9, 2012
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma statusL López-Corral, M E Sarasquete, S Beà, et al.
Pageof 8